SCHEMBL1008418

SCHEMBL1008418

CCCc1ccc2c(c1)nc(N)c1ncc(CCc3ccc(OC)cc3C)cc12

nearest known ligand 0.77

Predicted protein targets (top 1)

geneUniProtsupporting neighboursconfidence
TLR7 Q9NYK1 20/20 0.77

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1060029 0.94 TLR7 (0.74) TLR7
SCHEMBL1009605 0.90 TLR7 (0.77) TLR7
SCHEMBL1061173 0.90 TLR7 (0.77) TLR7
SCHEMBL1006099 0.89 TLR7 (0.76) TLR7
SCHEMBL16996998 0.89 TLR7 (0.75) TLR7
SCHEMBL18598565 0.89 TLR7 (0.75) TLR7
SCHEMBL17001190 0.89 TLR7 (0.75) TLR7
SCHEMBL18598573 0.89 TLR7 (0.75) TLR7
SCHEMBL1060581 0.88 TLR7 (0.72) TLR7
SCHEMBL12723400 0.88 TLR7 (0.77) TLR7

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2268618-A1 COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS IRM LLC (BM) 2011-01-05 EP claimed
WO-2009111337-A1 COMPOUNDS AND COMPOSITIONS AS TLR ACTIVITY MODULATORS IRM LLC (BM) 2009-09-11 WO claimed
EP-2459216-B1 IMMUNOGENIC COMPOSITIONS INCLUDING TLR ACTIVITY MODULATORS NOVARTIS AG (CH) 2013-10-30 EP disclosed
EP-2558069-A1 BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF Novartis AG (CH) 2013-02-20 EP disclosed
WO-2011130379-A1 BENZONAPTHYRIDINE COMPOSITIONS AND USES THEREOF NOVARTIS AG (CH) 2011-10-20 WO disclosed